Innovative NGS technology for gene expression profiling

Innovative NGS technology for gene expression profiling

January 09, 2017

We’ve got 6 reasons for you to move beyond qPCR for gene expression profiling! QIAGEN’s QIAseq Targeted RNA Panels offer you a simple and complete Sample to Insight solution for pathway- or disease-focused gene expression profiling with unmatched accuracy, sensitivity, specificity, reproducibility and high throughput.

  • Accurate results empowered by unique molecular indices (UMIs) and single primer extension (SPE) technology

  • Fold-change results supported by a free, integrated online data analysis tool

  • Profile hundreds of genes in hundreds of samples in one day

  • Biology-driven content supported by 170+ pathway-focused panels

  • Reproducible results ensured by the built-in controls for gDNA contamination and HKG assays

  • Easy-to-use custom builder for building your unique panels

 

 

How to ensure your research grant goes further when it comes to NGS library prep-Qiagen

How to ensure your research grant goes further when it comes to NGS library prep-Qiagen

Got thousands of library prep samples? Worried about inconsistency, increased re-run rates and escalating costs? Enter a world of convenience and flexibility with automated NGS library prep and combine the flexibility of QIAGEN’s QIAseq FX technology with the convenience of automation to turbocharge your library prep with Qiagen automation-friendly QIAseq FX DNA Library kit.

August 07, 2019 More +
Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Multiplicom is proud to launch Clarigo™, a new CE-IVD1 non-invasive prenatal test (NIPT). This highly accurate blood test will enable genetic analysis laboratories to detect the presence or absence of major chromosomal abnormalities such as trisomy 21 (Down’s syndrome), 18 (Edwards’ syndrome) and 13 (Patau syndrome), in the fetus, as early as in the first trimester of pregnancy by analysis of the fetus’s DNA in the maternal blood.

October 22, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us